Tropic Biosciences

Tropic Biosciences

Private
NorwichHealthcare & Life Scienceshttp://tropic.bio

Last Round

Series C

Mar 13, 2026

Total Funding Raised

$143.5M

Company Overview

Tropic Biosciences is an agricultural biotechnology company that develops high-performing commercial varieties of tropical crops like bananas, coffee, and rice using gene-editing technologies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene editingGEiGSagricultural biotechnologyGene Editing induced Gene SilencingagtechRNA interferenceRNAigene silencingnon-transgenic gene editingCRISPRtrait developmenttropical cropsprecision breedingdisease resistant cropstechnology licensingcrop geneticsPanama Disease resistancegene-edited coffeelivestock genetics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tropic Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Tropic Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series CMar 13, 2026
VC RoundJul 6, 2022
Series BJun 3, 2020
Series AJun 14, 2018

Key People

Founding team and executive leadership

Gilad Gershon

Co-Founder, CEO

Founding Team

Mark Williams

Chief Financial Officer

Executive Team

Tropic Biosciences Investors

Notable investors and investment history

InvestorRounds
Just ClimateSeries C
DisruptADVC Round
TemasekSeries C
Bits x BitesSeries B, Series A
ForbionSeries C
Skyviews Life ScienceVC Round, Series B
Sucden VenturesSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    $105M round completed.

  • Mar 12, 2026

    Siddarth Shrikanth joins the Board of Directors.

Tropic Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Tropic Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Tropic Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorwich
Employee Range153
Year Founded2016
Last FundingMar 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.